Young C J, Sweeney J L, Hunter A
Colorectal Unit, Royal Adelaide Hospital, South Australia, Australia.
Aust N Z J Surg. 2000 Sep;70(9):635-8. doi: 10.1046/j.1440-1622.2000.01916.x.
Delayed diagnosis of colorectal cancer (CRC) continues to produce anxiety and is associated with the assumption that disease stage and survival will be worse. The aims of the present study were to assess the prevalence and reasons for delay in the diagnosis of CRC, and the effects of delay, gender, age and tumour site on the stage of disease.
A retrospective study of 100 patients presenting with CRC during a 1-year period was performed. Delay was defined to have occurred if more than a 3-month period had lapsed from the time when initial symptoms were clearly established to the time of operation. Data were collected on principal presenting symptoms, time to first presentation to a doctor, time to diagnosis and treatment, reasons for delay, diagnostic procedures, tumour site, operation, and Australian clinicopathological (ACP) stage of the tumour.
Thirty-four patients had a delay in diagnosis of their cancer. In 18 patients (53%) delay was attributable to patient reasons; in 13 patients (38%) delay was attributable to doctor-related delay and in three patients (9%) it was attributable to both. Male patients were more likely to have patient-related delay (31% for male patients vs 10% for female patients; P = 0.011). Patients with delay were less likely to have a stage A tumour (6% for delay group vs 21% for non-delay group; P = 0.04). Male patients were less likely to have a stage A tumour than female patients (8% for male patients vs 25% for female patients; P = 0.018), but the effect of delay on stage disappeared when gender and tumour site were controlled in a logistic regression model.
The present study suggests some areas where improvements may be made concerning early diagnosis and treatment of patients with CRC.
结直肠癌(CRC)的延迟诊断持续引发焦虑,且常伴随着疾病分期和生存率较差的假设。本研究的目的是评估CRC诊断延迟的患病率及原因,以及延迟、性别、年龄和肿瘤部位对疾病分期的影响。
对100例在1年期间确诊为CRC的患者进行回顾性研究。如果从明确出现初始症状到手术时已超过3个月,则定义为发生了延迟。收集的数据包括主要症状、首次就诊时间、诊断和治疗时间、延迟原因、诊断程序、肿瘤部位、手术以及肿瘤的澳大利亚临床病理(ACP)分期。
34例患者存在癌症诊断延迟。18例患者(53%)的延迟归因于患者自身原因;13例患者(38%)的延迟归因于医生相关延迟,3例患者(9%)的延迟归因于两者。男性患者更易出现与患者相关的延迟(男性患者为31%,女性患者为10%;P = 0.011)。延迟诊断的患者患A期肿瘤的可能性较小(延迟组为6%,非延迟组为21%;P = 0.04)。男性患者患A期肿瘤的可能性低于女性患者(男性患者为8%,女性患者为25%;P = 0.018),但在逻辑回归模型中对性别和肿瘤部位进行控制后,延迟对分期的影响消失。
本研究提示了一些在CRC患者早期诊断和治疗方面可能需要改进的领域。